| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $459K | — | +5.1% |
| Cost of Revenue | $83K | — | +7.1% |
| Gross Profit | $375K | — | +4.6% |
| R&D Expense | $6K | — | +0.0% |
| SG&A Expense | $315K | — | -10.1% |
| Operating Income | $46K | — | +457.7% |
| Pre-tax Income | $20K | — | +152.2% |
| Net Income | $20K | — | +152.1% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $174K | +99.6% | +184.4% |
| Accounts Receivable | $194K | -11.4% | -15.4% |
| Inventory | $182K | +14.3% | +3.1% |
| Current Assets | $651K | +15.6% | +8.4% |
| Total Assets | $854K | +2.8% | -9.2% |
| Current Liabilities | $4.9M | +3.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $99K | — | +469.5% |
| Investing Cash Flow | $2K | — | — |
| Financing Cash Flow | -$15K | — | +15.7% |
| +6.3% |
| Total Liabilities | $5.1M | +3.4% | +5.2% |
| Stockholders' Equity | -$4.2M | -3.5% | -8.7% |